TCG Crossover Management, LLC Q3 2023 significant ownership

Add to watchlist

TCG Crossover Management, LLC is required to file a 13D/G report to the SEC when the ownership of a company's total stock issue exceeds 5%.

TCG Crossover Management, LLC Q3 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Silence Therapeutics plcAugust 19, 20226,314,6255.9%
CymaBay Therapeutics, Inc.November 29, 20215,905,4007.0%
Cogent Biosciences, Inc.November 17, 20212,716,0426.8%
Tyra Biosciences, Inc.September 29, 2021937,5002.2%
Viridian Therapeutics, Inc.\DESeptember 29, 20211,314,0008.2%

Compare quarters

Export TCG Crossover Management, LLC's holdings

CSVXLS